The Global Cancer Gene Therapy Market Size was estimated at USD 621.65 million in 2023 and is projected to reach USD 1661.18 million by 2029, exhibiting a CAGR of 17.80% during the forecast period.
The USA market for Global Cancer Gene Therapy market is estimated to increase from USD million in 2023 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The China market for Global Cancer Gene Therapy market is estimated to increase from USD million in 2023 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The Europe market for Global Cancer Gene Therapy market is estimated to increase from USD million in 2023 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
Report Overview:
Cancer could be defined as uncontrolled cell growth in the body leading to organ malfunction. If untreated, it can lead to death. Uncontrolled growth of cell is managed by the body in several ways, one of them is by deploying white blood cells to detect and eradicate these cancerous cells. It has been discovered that the immune system could be manipulated to influence cancerous cells to destroy itself.
This report provides a deep insight into the global Cancer Gene Therapy market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porters five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Cancer Gene Therapy Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Cancer Gene Therapy market in any manner.
Global Cancer Gene Therapy Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
- Adaptimmune
- Bluebird bio
- Celgene
- Shanghai Sunway Biotech
- Shenzhen SiBiono GeneTech
- SynerGene Therapeutics
- Altor BioScience
- Amgen
- Argenx
- BioCancell
- GlaxoSmithKline
- Merck
- OncoGenex Pharmaceuticals
- Transgene
Market Segmentation (by Type)
- Oncolytic Virotherapy
- Gene Transfer
- Gene-Induced Immunotherapy
Market Segmentation (by Application)
- Hospitals
- Diagnostics Centers
- Research Institutes
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Cancer Gene Therapy Market
- Overview of the regional outlook of the Cancer Gene Therapy Market:
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porters five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Cancer Gene Therapy Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Cancer Gene Therapy
1.2 Key Market Segments
1.2.1 Cancer Gene Therapy Segment by Type
1.2.2 Cancer Gene Therapy Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Cancer Gene Therapy Market Overview
2.1 Global Market Overview
2.1.1 Global Cancer Gene Therapy Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Cancer Gene Therapy Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Cancer Gene Therapy Market Competitive Landscape
3.1 Global Cancer Gene Therapy Sales by Manufacturers (2019-2024)
3.2 Global Cancer Gene Therapy Revenue Market Share by Manufacturers (2019-2024)
3.3 Cancer Gene Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Cancer Gene Therapy Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Cancer Gene Therapy Sales Sites, Area Served, Product Type
3.6 Cancer Gene Therapy Market Competitive Situation and Trends
3.6.1 Cancer Gene Therapy Market Concentration Rate
3.6.2 Global 5 and 10 Largest Cancer Gene Therapy Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Cancer Gene Therapy Industry Chain Analysis
4.1 Cancer Gene Therapy Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Cancer Gene Therapy Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Cancer Gene Therapy Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Cancer Gene Therapy Sales Market Share by Type (2019-2024)
6.3 Global Cancer Gene Therapy Market Size Market Share by Type (2019-2024)
6.4 Global Cancer Gene Therapy Price by Type (2019-2024)
7 Cancer Gene Therapy Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Cancer Gene Therapy Market Sales by Application (2019-2024)
7.3 Global Cancer Gene Therapy Market Size (M USD) by Application (2019-2024)
7.4 Global Cancer Gene Therapy Sales Growth Rate by Application (2019-2024)
8 Cancer Gene Therapy Market Segmentation by Region
8.1 Global Cancer Gene Therapy Sales by Region
8.1.1 Global Cancer Gene Therapy Sales by Region
8.1.2 Global Cancer Gene Therapy Sales Market Share by Region
8.2 North America
8.2.1 North America Cancer Gene Therapy Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Cancer Gene Therapy Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Cancer Gene Therapy Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Cancer Gene Therapy Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Cancer Gene Therapy Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Adaptimmune
9.1.1 Adaptimmune Cancer Gene Therapy Basic Information
9.1.2 Adaptimmune Cancer Gene Therapy Product Overview
9.1.3 Adaptimmune Cancer Gene Therapy Product Market Performance
9.1.4 Adaptimmune Business Overview
9.1.5 Adaptimmune Cancer Gene Therapy SWOT Analysis
9.1.6 Adaptimmune Recent Developments
9.2 Bluebird bio
9.2.1 Bluebird bio Cancer Gene Therapy Basic Information
9.2.2 Bluebird bio Cancer Gene Therapy Product Overview
9.2.3 Bluebird bio Cancer Gene Therapy Product Market Performance
9.2.4 Bluebird bio Business Overview
9.2.5 Bluebird bio Cancer Gene Therapy SWOT Analysis
9.2.6 Bluebird bio Recent Developments
9.3 Celgene
9.3.1 Celgene Cancer Gene Therapy Basic Information
9.3.2 Celgene Cancer Gene Therapy Product Overview
9.3.3 Celgene Cancer Gene Therapy Product Market Performance
9.3.4 Celgene Cancer Gene Therapy SWOT Analysis
9.3.5 Celgene Business Overview
9.3.6 Celgene Recent Developments
9.4 Shanghai Sunway Biotech
9.4.1 Shanghai Sunway Biotech Cancer Gene Therapy Basic Information
9.4.2 Shanghai Sunway Biotech Cancer Gene Therapy Product Overview
9.4.3 Shanghai Sunway Biotech Cancer Gene Therapy Product Market Performance
9.4.4 Shanghai Sunway Biotech Business Overview
9.4.5 Shanghai Sunway Biotech Recent Developments
9.5 Shenzhen SiBiono GeneTech
9.5.1 Shenzhen SiBiono GeneTech Cancer Gene Therapy Basic Information
9.5.2 Shenzhen SiBiono GeneTech Cancer Gene Therapy Product Overview
9.5.3 Shenzhen SiBiono GeneTech Cancer Gene Therapy Product Market Performance
9.5.4 Shenzhen SiBiono GeneTech Business Overview
9.5.5 Shenzhen SiBiono GeneTech Recent Developments
9.6 SynerGene Therapeutics
9.6.1 SynerGene Therapeutics Cancer Gene Therapy Basic Information
9.6.2 SynerGene Therapeutics Cancer Gene Therapy Product Overview
9.6.3 SynerGene Therapeutics Cancer Gene Therapy Product Market Performance
9.6.4 SynerGene Therapeutics Business Overview
9.6.5 SynerGene Therapeutics Recent Developments
9.7 Altor BioScience
9.7.1 Altor BioScience Cancer Gene Therapy Basic Information
9.7.2 Altor BioScience Cancer Gene Therapy Product Overview
9.7.3 Altor BioScience Cancer Gene Therapy Product Market Performance
9.7.4 Altor BioScience Business Overview
9.7.5 Altor BioScience Recent Developments
9.8 Amgen
9.8.1 Amgen Cancer Gene Therapy Basic Information
9.8.2 Amgen Cancer Gene Therapy Product Overview
9.8.3 Amgen Cancer Gene Therapy Product Market Performance
9.8.4 Amgen Business Overview
9.8.5 Amgen Recent Developments
9.9 Argenx
9.9.1 Argenx Cancer Gene Therapy Basic Information
9.9.2 Argenx Cancer Gene Therapy Product Overview
9.9.3 Argenx Cancer Gene Therapy Product Market Performance
9.9.4 Argenx Business Overview
9.9.5 Argenx Recent Developments
9.10 BioCancell
9.10.1 BioCancell Cancer Gene Therapy Basic Information
9.10.2 BioCancell Cancer Gene Therapy Product Overview
9.10.3 BioCancell Cancer Gene Therapy Product Market Performance
9.10.4 BioCancell Business Overview
9.10.5 BioCancell Recent Developments
9.11 GlaxoSmithKline
9.11.1 GlaxoSmithKline Cancer Gene Therapy Basic Information
9.11.2 GlaxoSmithKline Cancer Gene Therapy Product Overview
9.11.3 GlaxoSmithKline Cancer Gene Therapy Product Market Performance
9.11.4 GlaxoSmithKline Business Overview
9.11.5 GlaxoSmithKline Recent Developments
9.12 Merck
9.12.1 Merck Cancer Gene Therapy Basic Information
9.12.2 Merck Cancer Gene Therapy Product Overview
9.12.3 Merck Cancer Gene Therapy Product Market Performance
9.12.4 Merck Business Overview
9.12.5 Merck Recent Developments
9.13 OncoGenex Pharmaceuticals
9.13.1 OncoGenex Pharmaceuticals Cancer Gene Therapy Basic Information
9.13.2 OncoGenex Pharmaceuticals Cancer Gene Therapy Product Overview
9.13.3 OncoGenex Pharmaceuticals Cancer Gene Therapy Product Market Performance
9.13.4 OncoGenex Pharmaceuticals Business Overview
9.13.5 OncoGenex Pharmaceuticals Recent Developments
9.14 Transgene
9.14.1 Transgene Cancer Gene Therapy Basic Information
9.14.2 Transgene Cancer Gene Therapy Product Overview
9.14.3 Transgene Cancer Gene Therapy Product Market Performance
9.14.4 Transgene Business Overview
9.14.5 Transgene Recent Developments
10 Cancer Gene Therapy Market Forecast by Region
10.1 Global Cancer Gene Therapy Market Size Forecast
10.2 Global Cancer Gene Therapy Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Cancer Gene Therapy Market Size Forecast by Country
10.2.3 Asia Pacific Cancer Gene Therapy Market Size Forecast by Region
10.2.4 South America Cancer Gene Therapy Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Cancer Gene Therapy by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Cancer Gene Therapy Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Cancer Gene Therapy by Type (2025-2030)
11.1.2 Global Cancer Gene Therapy Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Cancer Gene Therapy by Type (2025-2030)
11.2 Global Cancer Gene Therapy Market Forecast by Application (2025-2030)
11.2.1 Global Cancer Gene Therapy Sales (K Units) Forecast by Application
11.2.2 Global Cancer Gene Therapy Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Cancer Gene Therapy Market Size Comparison by Region (M USD)
Table 5. Global Cancer Gene Therapy Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Cancer Gene Therapy Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Cancer Gene Therapy Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Cancer Gene Therapy Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Gene Therapy as of 2022)
Table 10. Global Market Cancer Gene Therapy Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Cancer Gene Therapy Sales Sites and Area Served
Table 12. Manufacturers Cancer Gene Therapy Product Type
Table 13. Global Cancer Gene Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Cancer Gene Therapy
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Cancer Gene Therapy Market Challenges
Table 22. Global Cancer Gene Therapy Sales by Type (K Units)
Table 23. Global Cancer Gene Therapy Market Size by Type (M USD)
Table 24. Global Cancer Gene Therapy Sales (K Units) by Type (2019-2024)
Table 25. Global Cancer Gene Therapy Sales Market Share by Type (2019-2024)
Table 26. Global Cancer Gene Therapy Market Size (M USD) by Type (2019-2024)
Table 27. Global Cancer Gene Therapy Market Size Share by Type (2019-2024)
Table 28. Global Cancer Gene Therapy Price (USD/Unit) by Type (2019-2024)
Table 29. Global Cancer Gene Therapy Sales (K Units) by Application
Table 30. Global Cancer Gene Therapy Market Size by Application
Table 31. Global Cancer Gene Therapy Sales by Application (2019-2024) & (K Units)
Table 32. Global Cancer Gene Therapy Sales Market Share by Application (2019-2024)
Table 33. Global Cancer Gene Therapy Sales by Application (2019-2024) & (M USD)
Table 34. Global Cancer Gene Therapy Market Share by Application (2019-2024)
Table 35. Global Cancer Gene Therapy Sales Growth Rate by Application (2019-2024)
Table 36. Global Cancer Gene Therapy Sales by Region (2019-2024) & (K Units)
Table 37. Global Cancer Gene Therapy Sales Market Share by Region (2019-2024)
Table 38. North America Cancer Gene Therapy Sales by Country (2019-2024) & (K Units)
Table 39. Europe Cancer Gene Therapy Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Cancer Gene Therapy Sales by Region (2019-2024) & (K Units)
Table 41. South America Cancer Gene Therapy Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Cancer Gene Therapy Sales by Region (2019-2024) & (K Units)
Table 43. Adaptimmune Cancer Gene Therapy Basic Information
Table 44. Adaptimmune Cancer Gene Therapy Product Overview
Table 45. Adaptimmune Cancer Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Adaptimmune Business Overview
Table 47. Adaptimmune Cancer Gene Therapy SWOT Analysis
Table 48. Adaptimmune Recent Developments
Table 49. Bluebird bio Cancer Gene Therapy Basic Information
Table 50. Bluebird bio Cancer Gene Therapy Product Overview
Table 51. Bluebird bio Cancer Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Bluebird bio Business Overview
Table 53. Bluebird bio Cancer Gene Therapy SWOT Analysis
Table 54. Bluebird bio Recent Developments
Table 55. Celgene Cancer Gene Therapy Basic Information
Table 56. Celgene Cancer Gene Therapy Product Overview
Table 57. Celgene Cancer Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Celgene Cancer Gene Therapy SWOT Analysis
Table 59. Celgene Business Overview
Table 60. Celgene Recent Developments
Table 61. Shanghai Sunway Biotech Cancer Gene Therapy Basic Information
Table 62. Shanghai Sunway Biotech Cancer Gene Therapy Product Overview
Table 63. Shanghai Sunway Biotech Cancer Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Shanghai Sunway Biotech Business Overview
Table 65. Shanghai Sunway Biotech Recent Developments
Table 66. Shenzhen SiBiono GeneTech Cancer Gene Therapy Basic Information
Table 67. Shenzhen SiBiono GeneTech Cancer Gene Therapy Product Overview
Table 68. Shenzhen SiBiono GeneTech Cancer Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Shenzhen SiBiono GeneTech Business Overview
Table 70. Shenzhen SiBiono GeneTech Recent Developments
Table 71. SynerGene Therapeutics Cancer Gene Therapy Basic Information
Table 72. SynerGene Therapeutics Cancer Gene Therapy Product Overview
Table 73. SynerGene Therapeutics Cancer Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. SynerGene Therapeutics Business Overview
Table 75. SynerGene Therapeutics Recent Developments
Table 76. Altor BioScience Cancer Gene Therapy Basic Information
Table 77. Altor BioScience Cancer Gene Therapy Product Overview
Table 78. Altor BioScience Cancer Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Altor BioScience Business Overview
Table 80. Altor BioScience Recent Developments
Table 81. Amgen Cancer Gene Therapy Basic Information
Table 82. Amgen Cancer Gene Therapy Product Overview
Table 83. Amgen Cancer Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Amgen Business Overview
Table 85. Amgen Recent Developments
Table 86. Argenx Cancer Gene Therapy Basic Information
Table 87. Argenx Cancer Gene Therapy Product Overview
Table 88. Argenx Cancer Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Argenx Business Overview
Table 90. Argenx Recent Developments
Table 91. BioCancell Cancer Gene Therapy Basic Information
Table 92. BioCancell Cancer Gene Therapy Product Overview
Table 93. BioCancell Cancer Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. BioCancell Business Overview
Table 95. BioCancell Recent Developments
Table 96. GlaxoSmithKline Cancer Gene Therapy Basic Information
Table 97. GlaxoSmithKline Cancer Gene Therapy Product Overview
Table 98. GlaxoSmithKline Cancer Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. GlaxoSmithKline Business Overview
Table 100. GlaxoSmithKline Recent Developments
Table 101. Merck Cancer Gene Therapy Basic Information
Table 102. Merck Cancer Gene Therapy Product Overview
Table 103. Merck Cancer Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Merck Business Overview
Table 105. Merck Recent Developments
Table 106. OncoGenex Pharmaceuticals Cancer Gene Therapy Basic Information
Table 107. OncoGenex Pharmaceuticals Cancer Gene Therapy Product Overview
Table 108. OncoGenex Pharmaceuticals Cancer Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. OncoGenex Pharmaceuticals Business Overview
Table 110. OncoGenex Pharmaceuticals Recent Developments
Table 111. Transgene Cancer Gene Therapy Basic Information
Table 112. Transgene Cancer Gene Therapy Product Overview
Table 113. Transgene Cancer Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. Transgene Business Overview
Table 115. Transgene Recent Developments
Table 116. Global Cancer Gene Therapy Sales Forecast by Region (2025-2030) & (K Units)
Table 117. Global Cancer Gene Therapy Market Size Forecast by Region (2025-2030) & (M USD)
Table 118. North America Cancer Gene Therapy Sales Forecast by Country (2025-2030) & (K Units)
Table 119. North America Cancer Gene Therapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 120. Europe Cancer Gene Therapy Sales Forecast by Country (2025-2030) & (K Units)
Table 121. Europe Cancer Gene Therapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 122. Asia Pacific Cancer Gene Therapy Sales Forecast by Region (2025-2030) & (K Units)
Table 123. Asia Pacific Cancer Gene Therapy Market Size Forecast by Region (2025-2030) & (M USD)
Table 124. South America Cancer Gene Therapy Sales Forecast by Country (2025-2030) & (K Units)
Table 125. South America Cancer Gene Therapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 126. Middle East and Africa Cancer Gene Therapy Consumption Forecast by Country (2025-2030) & (Units)
Table 127. Middle East and Africa Cancer Gene Therapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 128. Global Cancer Gene Therapy Sales Forecast by Type (2025-2030) & (K Units)
Table 129. Global Cancer Gene Therapy Market Size Forecast by Type (2025-2030) & (M USD)
Table 130. Global Cancer Gene Therapy Price Forecast by Type (2025-2030) & (USD/Unit)
Table 131. Global Cancer Gene Therapy Sales (K Units) Forecast by Application (2025-2030)
Table 132. Global Cancer Gene Therapy Market Size Forecast by Application (2025-2030) & (M USD)
List of Figures
Figure 1. Product Picture of Cancer Gene Therapy
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Cancer Gene Therapy Market Size (M USD), 2019-2030
Figure 5. Global Cancer Gene Therapy Market Size (M USD) (2019-2030)
Figure 6. Global Cancer Gene Therapy Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Cancer Gene Therapy Market Size by Country (M USD)
Figure 11. Cancer Gene Therapy Sales Share by Manufacturers in 2023
Figure 12. Global Cancer Gene Therapy Revenue Share by Manufacturers in 2023
Figure 13. Cancer Gene Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Cancer Gene Therapy Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Cancer Gene Therapy Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Cancer Gene Therapy Market Share by Type
Figure 18. Sales Market Share of Cancer Gene Therapy by Type (2019-2024)
Figure 19. Sales Market Share of Cancer Gene Therapy by Type in 2023
Figure 20. Market Size Share of Cancer Gene Therapy by Type (2019-2024)
Figure 21. Market Size Market Share of Cancer Gene Therapy by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Cancer Gene Therapy Market Share by Application
Figure 24. Global Cancer Gene Therapy Sales Market Share by Application (2019-2024)
Figure 25. Global Cancer Gene Therapy Sales Market Share by Application in 2023
Figure 26. Global Cancer Gene Therapy Market Share by Application (2019-2024)
Figure 27. Global Cancer Gene Therapy Market Share by Application in 2023
Figure 28. Global Cancer Gene Therapy Sales Growth Rate by Application (2019-2024)
Figure 29. Global Cancer Gene Therapy Sales Market Share by Region (2019-2024)
Figure 30. North America Cancer Gene Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Cancer Gene Therapy Sales Market Share by Country in 2023
Figure 32. U.S. Cancer Gene Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Cancer Gene Therapy Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Cancer Gene Therapy Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Cancer Gene Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Cancer Gene Therapy Sales Market Share by Country in 2023
Figure 37. Germany Cancer Gene Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Cancer Gene Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Cancer Gene Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Cancer Gene Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Cancer Gene Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Cancer Gene Therapy Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Cancer Gene Therapy Sales Market Share by Region in 2023
Figure 44. China Cancer Gene Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Cancer Gene Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Cancer Gene Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Cancer Gene Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Cancer Gene Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Cancer Gene Therapy Sales and Growth Rate (K Units)
Figure 50. South America Cancer Gene Therapy Sales Market Share by Country in 2023
Figure 51. Brazil Cancer Gene Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Cancer Gene Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Cancer Gene Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Cancer Gene Therapy Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Cancer Gene Therapy Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Cancer Gene Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Cancer Gene Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Cancer Gene Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Cancer Gene Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Cancer Gene Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Cancer Gene Therapy Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Cancer Gene Therapy Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Cancer Gene Therapy Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Cancer Gene Therapy Market Share Forecast by Type (2025-2030)
Figure 65. Global Cancer Gene Therapy Sales Forecast by Application (2025-2030)
Figure 66. Global Cancer Gene Therapy Market Share Forecast by Application (2025-2030)
